Healthcare provider profile · identity verified

Salam Hawa, MD

Family Practice · GANSEVOORT, NY · NPI 1851886451

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	227	61
Atorvastatin Calcium	Atorvastatin Calcium	207	63
Omeprazole	Omeprazole	182	44
Albuterol Sulfate Hfa	Albuterol Sulfate	141	44
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	126	15
Amlodipine Besylate	Amlodipine Besylate	115	34
Gabapentin	Gabapentin	113	30
Levothyroxine Sodium	Levothyroxine Sodium	97	31
Duloxetine Hcl	Duloxetine Hcl	94	20
Hydrochlorothiazide	Hydrochlorothiazide	81	24
Metformin Hcl Er	Metformin Hcl	81	19
Metoprolol Succinate	Metoprolol Succinate	77	23
Tamsulosin Hcl	Tamsulosin Hcl	76	27
Rosuvastatin Calcium	Rosuvastatin Calcium	71	24
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	68	12
Losartan Potassium	Losartan Potassium	60	22
Escitalopram Oxalate	Escitalopram Oxalate	56	15
Venlafaxine Hcl Er	Venlafaxine Hcl	56	suppressed
Tramadol Hcl	Tramadol Hcl	53	15
Simvastatin	Simvastatin	52	17
Buspirone Hcl	Buspirone Hcl	50	11
Fluoxetine Hcl	Fluoxetine Hcl	48	12
Alprazolam	Alprazolam	46	14
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Famotidine	Famotidine	45	12
Finasteride	Finasteride	44	12
Pantoprazole Sodium	Pantoprazole Sodium	44	15
Eliquis	Apixaban	43	14
Clonazepam	Clonazepam	42	14
Pregabalin	Pregabalin	41	suppressed
Carvedilol	Carvedilol	40	12
Potassium Chloride	Potassium Chloride	39	11
Metformin Hcl	Metformin Hcl	38	13
Trazodone Hcl	Trazodone Hcl	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	37	17
Prednisone	Prednisone	37	33
Sertraline Hcl	Sertraline Hcl	37	14
Furosemide	Furosemide	36	14
Alendronate Sodium	Alendronate Sodium	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	17
Morphine Sulfate Er	Morphine Sulfate	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	14
Doxycycline Hyclate	Doxycycline Hyclate	33	28
Glipizide Er	Glipizide	33	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Olanzapine	Olanzapine	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Doxepin Hcl	Doxepin Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Tivicay	Dolutegravir Sodium	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Cephalexin	Cephalexin	21	17
Ibuprofen	Ibuprofen	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Complera	Emtricita/Rilpivirine/Tenof Df	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Meloxicam	Meloxicam	18	14
Mirtazapine	Mirtazapine	18	suppressed
Nystatin	Nystatin	18	suppressed
Ozempic	Semaglutide	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	13
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Eplerenone	Eplerenone	16	suppressed
Mupirocin	Mupirocin	16	16
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Atenolol	Atenolol	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Torsemide	Torsemide	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Temazepam	Temazepam	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Valsartan	Valsartan	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Isentress	Raltegravir Potassium	11	suppressed
Pifeltro	Doravirine	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error